CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.
Sanna HallamiesLiisa M PelttariPaula Poikonen-SakselaAntti JekunenArja Jukkola-VuorinenPäivi AuvinenCarl BlomqvistKristiina AittomäkiJohanna MattsonHeli NevanlinnaPublished in: BMC cancer (2017)
These data suggest that the CHEK2 c.1100delC mutation is associated with an increased risk for MBC in the Finnish population.